News
We came across a bullish thesis on Abbott Laboratories on r/ValueInvesting subreddit by anonymous_sheep1. In this article, we ...
2d
Zacks Investment Research on MSNInvestors Heavily Search Abbott Laboratories (ABT): Here is What You Need to KnowAbbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...
Abbott Laboratories CEO Robert Ford unpacked his company’s latest quarterly report in a Thursday interview with CNBC’s Jim ...
"Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly ...
Over the past few years, Abbott Laboratories' (ABT 2.65%) business has been a bit of a roller coaster. The pandemic disrupted its medical device business, but it was later able to smooth out those ...
Explore more
Abbott Laboratories closed 6.52% below its 52-week high of $141.23, which the company reached on March 4th.
Abbott Labs was selling at roughly $21 per share in June 2009. If you had invested in Abbott in 2008, when the stock's average price was $25, and started with $1,000, you would have had enough to ...
Abbott Laboratories first quarter profits eclipsed $2.4 billion thanks to a surge in sales of Covid-19 diagnostic tests as demand grew with the spread of the Omicron variant earlier this year.
President Trump’s made-for-TV unboxing of Abbott Laboratories’ toaster-sized testing instrument beamed into millions of households last month as he displayed the unit in the Rose Garden.
Abbott Laboratories reported $1 billion in fourth quarter profits despite an “expected year-over-year decline in Covid-19 testing-related sales,” the company said Wednesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results